Unity Biotechnology, Inc.UBXNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank13
3Y CAGR-33.0%
5Y CAGR-20.1%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-33.0%/yr
vs -47.3%/yr prior
5Y CAGR
-20.1%/yr
Recent deceleration
Acceleration
+14.3pp
Accelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $867000.00 | -95.6% |
| 2023 | $19.70M | +803.6% |
| 2022 | $2.18M | -24.3% |
| 2021 | $2.88M | -16.5% |
| 2020 | $3.45M | +29.5% |
| 2019 | $2.66M | +22.2% |
| 2018 | $2.18M | -94.2% |
| 2017 | $37.37M | +24326.8% |
| 2016 | $153000.00 | - |